Robert Bruce Stewart
Direktor/Vorstandsmitglied bei Ablaris Therapeutics, Inc.
Profil
Robert Bruce Stewart is the founder of Acacia Research Corp.
(founded in 1991 and 1993) and Arrowhead Pharmaceuticals, Inc. (founded in 1989).
He held the title of Executive Chairman at Arrowhead Pharmaceuticals from 2010 to 2011.
Currently, he is a Director at Ablaris Therapeutics, Inc. and Tego Biosciences Corp.
He previously held the position of Director at Calando Pharmaceuticals, Inc. and Insert Therapeutics, Inc. He was also the President of Annandale Corp.
from 1977 to 1992.
Aktive Positionen von Robert Bruce Stewart
| Unternehmen | Position | Beginn |
|---|---|---|
| Ablaris Therapeutics, Inc. | Direktor/Vorstandsmitglied | - |
| Tego Biosciences Corp. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Robert Bruce Stewart
| Unternehmen | Position | Ende |
|---|---|---|
| Acacia Research Corp. /Old/ | Gründer | 17.06.2009 |
Insert Therapeutics, Inc.
 Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | Direktor/Vorstandsmitglied | 08.09.2008 |
| Annandale Corp. | Präsident | 01.01.1992 |
| ACACIA RESEARCH CORPORATION | Gründer | - |
Calando Pharmaceuticals, Inc.
 Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| ACACIA RESEARCH CORPORATION | Commercial Services |
| Private Unternehmen | 6 |
|---|---|
| Acacia Research Corp. /Old/ | Finance |
Calando Pharmaceuticals, Inc.
Calando Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calando Pharmaceuticals, Inc. engages in the design and development of drug-delivery-enhanced small molecule therapeutics. The company was established in 2000 and is headquartered in Pasadena, CA. | Health Technology |
Insert Therapeutics, Inc.
Insert Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Insert Therapeutics, Inc. researches and develops therapeutic products. It is using nano-engineered, polymeric delivery system, Cyclosert(TM), to design, develop and commercialize drug-delivery-enhanced small-molecule therapeutics and nucleic acids. Cyclosert uses cyclodextrins as building blocks to create biocompatible materials - linear cyclodextrin-containing polymers that are non-toxic and non-immunogenic at therapeutic doses. The company was founded in February 2000 by Mark Davis and is located in Pasadena, CA | Commercial Services |
| Annandale Corp. | Commercial Services |
| Ablaris Therapeutics, Inc. | |
| Tego Biosciences Corp. |
